These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16466975)

  • 21. Homocysteine and osteoporotic fractures--culprit or bystander?
    Raisz LG
    N Engl J Med; 2004 May; 350(20):2089-90. PubMed ID: 15141048
    [No Abstract]   [Full Text] [Related]  

  • 22. [Poor bone quality in diabetes and arterioscelerosis].
    Saito M
    Clin Calcium; 2009 Sep; 19(9):1257-68. PubMed ID: 19721196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Traveling to the world of osteoporosis].
    Ferrer Cañabate J; Egea Mellado JM; Martínez Hernández P; Tovar Zapata I
    An Med Interna; 2000 Aug; 17(8):395-8. PubMed ID: 11218984
    [No Abstract]   [Full Text] [Related]  

  • 24. Future developments in therapy.
    Isales CM; McDonald JM
    Ann N Y Acad Sci; 2007 Nov; 1117():258-63. PubMed ID: 17584984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Elevated plasma concentration of homocysteine, low level of vitamin B6, pyridoxal, and vitamin D insufficiency in patients with hip fracture: a possible explanation for detrimental cross-link pattern in bone collagen].
    Saito M
    Clin Calcium; 2006 Dec; 16(12):1974-84. PubMed ID: 17142927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vitamin K and bone quality].
    Hara K; Akiyama Y
    Clin Calcium; 2007 Nov; 17(11):1678-84. PubMed ID: 17982187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Metabolic aspects of fractures in old age].
    Stĕpán J; Pacovský V
    Cas Lek Cesk; 1984 Jan; 123(2):43-7. PubMed ID: 6692457
    [No Abstract]   [Full Text] [Related]  

  • 28. Homocysteine as a Pathological Biomarker for Bone Disease.
    Behera J; Bala J; Nuru M; Tyagi SC; Tyagi N
    J Cell Physiol; 2017 Oct; 232(10):2704-2709. PubMed ID: 27859269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental hyperhomocysteinemia disturbs bone metabolism in rats.
    Ozdem S; Samanci S; Tasatargil A; Yildiz A; Sadan G; Donmez L; Herrmann M
    Scand J Clin Lab Invest; 2007; 67(7):748-56. PubMed ID: 17852810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of vitamin D on bone mineral density; bone strength and fracture prevention].
    Okuizumi H; Harada A
    Clin Calcium; 2006 Jul; 16(7):1115-21. PubMed ID: 16816470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls.
    Saito M; Fujii K; Marumo K
    Calcif Tissue Int; 2006 Sep; 79(3):160-8. PubMed ID: 16969591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nutrition and bone health. Roles of vitamin C and vitamin B as regulators of bone mass and quality].
    Saito M
    Clin Calcium; 2009 Aug; 19(8):1192-9. PubMed ID: 19638704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone strength: what are we trying to measure?
    Currey JD
    Calcif Tissue Int; 2001 Apr; 68(4):205-10. PubMed ID: 11353945
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperhomocysteinemia: can't it account for retinoid-induced fracture proneness?
    Namazi MR; Feily A
    Indian J Dermatol Venereol Leprol; 2010; 76(2):186-7. PubMed ID: 20228554
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of collagen concentration and crosslink density on the biological, structural and mechanical properties of collagen-GAG scaffolds for bone tissue engineering.
    Tierney CM; Haugh MG; Liedl J; Mulcahy F; Hayes B; O'Brien FJ
    J Mech Behav Biomed Mater; 2009 Apr; 2(2):202-9. PubMed ID: 19627824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Collagen Organization on the Properties of Bone.
    Garnero P
    Calcif Tissue Int; 2015 Sep; 97(3):229-40. PubMed ID: 25894071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
    Perifanis V; Vyzantiadis T; Tziomalos K; Vakalopoulou S; Garipidou V; Athanassiou-Metaxa M; Harsoulis F
    Ann Hematol; 2007 Jan; 86(1):23-30. PubMed ID: 17013645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metabolic status and bone mineral density in patients with pseudarthrosis of long bones in hyperhomocysteinemia].
    Bezsmertnyĭ IuO
    Lik Sprava; 2013 Jun; (4):44-51. PubMed ID: 25095684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of primary osteoporosis with vitamin K2].
    Hosoi T
    Clin Calcium; 2007 Nov; 17(11):1727-30. PubMed ID: 17982193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Senile osteoporosis from the internal medicine and geriatric viewpoints. I].
    Schmidt UJ; Brüschke G; Grossmann I; Haase J; Ihle R; Mühlbach R; Reitzig P
    Dtsch Gesundheitsw; 1970 Mar; 25(11):477-80. PubMed ID: 5447201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.